Cha Medical and Bio Group said Wednesday that the group will hold the Global Forum on Future Medicine 2023 at Cha Bio Complex in Seongnam, Gyeonggi Province, on Oct. 27.

The forum will invite experts in stem cell research, regenerative medicine and cell and gene therapies, as well as officials from the government's regulatory agency.

“The forum will provide opportunities for us to share the latest trends and new findings in the stem cell and GCT research areas,” said Yoon Ho-sup, president of Cha Advanced Research Institute.

The forum will feature speeches from acclaimed experts, including Hiromitsu Nakauchi, a genetics professor at Stanford University School of Medicine; Hideyuki Okano, a physiology professor and the current dean of Keio University School of Medicine; and Kim Kwang-soo, a neuroscience professor at Harvard Medical School.

Professor Nakauchi will deliver his speech on stem cell research and its clinical applications during the forum’s first session.

In the afternoon sessions, Professor Okano will touch on regenerative therapy for spinal cord injuries, while Professor Kim will speak about stem cell therapy used for Parkinson’s disease.

The final session will consist of discussions about open innovation opportunities in the regenerative medicine sector, as well as the relevant regulatory challenges.

• ·Succession scheme taking shape at Lotte
• ·Born rich, promoted young: chaebol scions become president just after 40
• ·‘Korea could go extinct without proper immigration policy’: minister
• ·LTI Korea announces winners of 2023 Korea Translation Award
• ·Congresswoman redoubles calls for support to designate Nov. 22 as 'Kimchi Day'
• ·Ideal spouse material? Above
• ·Seoul high court sides with iPhone owners against Apple over ‘batterygate’
• ·Drug offences rise by nearly 50 percent on
• ·Congresswoman redoubles calls for support to designate Nov. 22 as 'Kimchi Day'
• ·Drug offences rise by nearly 50 percent on
• ·[KH Explains] Banks, regulators trade blame for snowballing ELS losses
• ·AliExpress vows to invest W10b to root out fake goods in Korea
• ·Seoul stocks end nearly flat on cautious note
• ·Yoon visits Busan after failed World Expo bid
• ·윤 대통령, 엑스포 불발 1주만에 부산행 “지역현안 완벽 추진”
• ·GC Biopharma breaks ground for Indonesia’s first blood products plant